PCK (ASX) Pain Diagnosis via blood test

Originally posted by Tech goose ↑

Breakthrough test reveals pain in colour

An on-the-spot blood test that identifies chronic pain by colour 'biomarkers' has the potential to revolutionise its diagnosis, Australian researchers say.

UpdatedUpdated 13 hours ago
It can be hard to know when a baby or dementia patient is in persistent pain because they either can't or struggle to communicate their level of suffering.

But a breakthrough blood test that identifies chronic pain using colour biomarkers could fix this challenging situation faced by many doctors.

The world-first test, called the 'painHS' test, was developed by a team of Australian scientists after discovering chronic pain is biologically a different colour in immune cells to regular acute pain.

The test is able to differentiate between the colours of pain in the blood using light measurement tools, immediately detecting those in chronic pain.

"We are literally quantifying the colour of pain," said neuroscientist Professor Mark Hutchinson, who will reveal the test at a meeting of the Faculty of Pain Medicine in Sydney on Sunday.

One in five people in Australia suffer chronic pain.

Prof Hutchinson believes this test will be a cost-effective way for doctors to accurately determine the severity of chronic pain in patients with back issues, cancer and migraine.

Those who are unable to describe their pain suffering, like very young children and those with dementia, will especially benefit, he says.

"Self-reporting (by patients) is still going to be key but what this does is that those forgotten people who are unable to communicate their pain conditions such as babies or people with dementia can now have their condition diagnosed and treated," he said.

It also has the potential to revolutionise pain treatment for animals, Prof Hutchinson said.

"Animals can't tell us if they're in pain but here we have a Dr Doolittle-type test that enables us to 'talk' to the animals, so we can find out if they are experiencing pain and then we can help them," he said.

It's hoped the painHS test will be ready for broader use by pain medicine physicians and GPs within 18 months.

.................................................................................................................................

Painchek will be well embedded in the world market by the time the blood test enters the market as a competitor, but are they going to be taking away a large percentage of market share???

Must say it does look like the painHS test will do very well in the animal sector

The choice between a short video or a blood sample,.....common sense suggests most will go for painchek.

Expand

At the end of the day it's going to come down to which one is more reliable and accurate. Hmmmm - but I guess with the blood test they will be able to kill two birds with one stone and test for other issues at the same time? Perhaps at the doctor's office/ within a hospital setting this one would be preferable. But how ironic - causing pain to test weather or not the patient is in pain LOL... In a home setting painchek would be the go IMO and pain - less hahahaha less is more...

Cheers
Red bar

No.	Vol.	Price($)
2	200916	3.9¢

No.

Vol.

Price($)

200916

3.9¢

Price($)	Vol.	No.
4.0¢	1491666	5

Price($)

Vol.

No.

4.0¢

1491666

No.	Vol.	Price($)
2	200916	0.039
2	306371	0.038
1	25000	0.037
1	114792	0.036
2	262933	0.035

No.

Vol.

Price($)

200916

0.039

306371

0.038

25000

0.037

114792

0.036

262933

0.035

Price($)	Vol.	No.
0.040	1491666	5
0.041	565454	2
0.042	362300	3
0.043	181299	2
0.044	475304	4

Price($)

Vol.

No.

0.040

1491666

0.041

565454

0.042

362300

0.043

181299

0.044

475304

(20min delay)
Last 3.9¢		Change -0.001(2.50%)		Mkt cap ! $63.79M

Open	High	Low	Value	Volume
4.0¢	4.0¢	3.9¢	$14.63K	374.0K

Pain Diagnosis via blood test, page-5

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Pain Diagnosis via blood test, page-5

Top Stories

Biome unveils three year revenue target up to $85M – but are 3Y targets enough to excite?

$550 million Jabiluka uranium offer comes unstuck as Government rules lease won't be renewed

Brine and shine: Arizona Lithium wins early stage eco approval to commence wellpad #2 at Prairie

PAM secures high-grade Chilean copper play in strong territory

KGL hits copper-silver-gold-zinc-lead massive sulphide intersection in NT

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News